ASX:CVS Cervantes (CVS) Stock Price, News & Analysis → The Gold Grab of the Century (From Colonial Metals) (Ad) Free CVS Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Cervantes alerts: Email Address Ad TranzactWhat is Medicare Supplement Insurance?Original Medicare helps covers a lot of hospital and medical services, but it still leaves some out- of- pocket medical costs to recipients. Make sure your family’s nest egg is protected from unpredictable medical expenses. Consider applying for a Medicare Supplement Insurance Plan that travels with you. Learn More Here About Cervantes Stock (ASX:CVS)Cervantes Corporation Limited engages in the exploration and evaluation of mineral resource projects in Australia. The company primarily explores for gold, as well as for nickel, cobalt, and base metals. It holds interests in the Primrose project located in the Murchison District of the Eastern Goldfields, Western Australia. Cervantes Corporation Limited was incorporated in 2001 and is headquartered in South Perth, Australia.Read More Ad Banyan Hill PublishingThe Best AI Stock to Own in the World Today is Trading for Just $25“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him CVS Stock News HeadlinesMarch 29, 2024 | yahoo.comIs Publix open on Easter 2024? Here’s what’s open and closed on SundayFebruary 11, 2024 | news.yahoo.comSenate passes bill for 7-day waiting period on gun buysApril 26, 2024 | Insiders Exposed (Ad)The Hard Truth About Investing For RetirementHere’s the cold, hard truth about investing: The more capital you have, the more risk averse you can afford to be. But when you’re staring down the barrel of retirement and you’ve only got 5, 10, 50 or $100,000 saved, you’ve got to be more aggressive. In an exclusive online training, the Market expert Steven Place is revealing a powerful “roadmap” that’s leading everyday investors to easy, triple-digit wins, even if they don’t have a lot of experience in trading.December 2, 2023 | usatoday.comAuthor Luis Mateo Díez wins Cervantes Prize, the Spanish-speaking world's top literary honorOctober 27, 2023 | usatoday.comCVS walkout ends; pharmacists cautiously optimistic amid promises of more staff and reliefOctober 17, 2023 | msn.comCHP: California woman rescued after SUV drove into San Joaquin River has diedOctober 13, 2023 | health.usnews.comJosie D. CervantesOctober 3, 2023 | latimes.comCVS Photo Coupon | October 2023April 26, 2024 | Prosper Trading Academy (Ad)These AI trades triggered this morning (545% return)If you think a market crash is possible in 2024, I don't know why you're not using this yet.August 2, 2023 | uk.finance.yahoo.comCVS - CVS Health CorporationJune 2, 2023 | health.usnews.comDr. Victoria CervantesMay 3, 2023 | uk.finance.yahoo.comCVS Health Corporation (CVS) stock price, news, quote & history – Yahoo FinanceFebruary 24, 2023 | usatoday.comWant to try natural deodorant? Native deodorant is Reviewed-approved and on sale at CVSFebruary 21, 2023 | usatoday.comKick-start your spring cleaning with CVS deals on Swiffer, Febreze and moreJanuary 16, 2023 | cbsnews.comCVS sued by nurse who was fired after she refused to prescribe birth control because of her religious beliefsAugust 24, 2022 | finance.yahoo.comThe Good, Bad & Kinda Weird Exercises People Try On TikTokAugust 9, 2022 | investing.comNYSE Tick Index (TIC.N)August 5, 2022 | ca.finance.yahoo.comTreace Announces Full Commercial Release of New Technologies for Bunion and Related Midfoot SurgeryJune 7, 2022 | finance.yahoo.comI have Alzheimer’s. Don’t feel sorry for me | GuestviewMay 29, 2022 | finance.yahoo.comAffimed Highlights Trial Designs of Three AFM24 Ongoing Clinical Studies at the Annual Meeting of the American Society of Clinical Oncology (ASCO)May 1, 2022 | msn.comDEA National Take Back Saturday: Here's where you can dispose old prescriptionsMarch 25, 2022 | proactiveinvestors.com.auReach Resources gets new CEO as it moves to become significant player in emerging circular economyFebruary 12, 2022 | msn.comUPDATE: 22-year-old man arrested for robbing Pensacola CVS at gunpointFebruary 12, 2022 | au.finance.yahoo.comUPDATE 3-CVS forecasts COVID vaccine business drop of up to 80% in 2022February 10, 2022 | msn.comMan in custody after Pensacola armed robberyFebruary 10, 2022 | yahoo.comPPD: Police searching for armed suspect who robbed CVSFebruary 10, 2022 | msn.comSuspect arrested in early morning armed robbery at CVSSee More Headlines Receive CVS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cervantes and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/14/2018Today4/26/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorBasic Materials Industry Gold Sub-IndustryN/A Current SymbolASX:CVS CUSIPN/A CIKN/A Webwww.cervantescorp.com.au Phone+61-8-64362300FaxN/AEmployees2,020Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio13.00 Current Ratio4.21 Quick Ratio4.21 Sales & Book Value Annual Sales$29,654.00 Price / Sales0.00 Cash FlowN/A Price / Cash Flow0.11 Book ValueA$0.00 per share Price / BookN/AMiscellaneous Outstanding Shares1,554,009,984Free FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key ExecutivesMr. Justin Vost (Age 50)Consultant Comp: $40kMr. Marcus F. Flis BSc (Hons) (Age 63)M.Sc., FAusIMM, Exploration Mang. & Non-Exec. Director Comp: $22.55kMr. Christopher Achurch B.Com.C.A., Company Sec.Key CompetitorsAben MineralsOTCMKTS:ABNAFAdelong GoldASX:ADGAlacer GoldOTCMKTS:ALIAFALACERGOLD/IDR UNRESTRASX:AQGAlchemy ResourcesASX:ALYView All Competitors CVS Stock Analysis - Frequently Asked Questions How were Cervantes' earnings last quarter? Cervantes Co. Limited (ASX:CVS) released its earnings results on Wednesday, March, 14th. The company reported $0.00 EPS for the quarter. What other stocks do shareholders of Cervantes own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cervantes investors own include Consumer Staples Select Sector SPDR Fund (XLP), RiverFront Dynamic US Flex-Cap ETF (RFFC), RiverFront Dynamic US Dividend Advantage ETF (RFDA), First Trust RiverFront Dynamic Developed International ETF (RFDI), ALPS ETF Trust - Riverfront Dynamic Unconstrained Income ETF (RFUN), Financial Select Sector SPDR Fund (XLF), iShares Core S&P Small-Cap ETF (IJR), PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund (HYS). This page (ASX:CVS) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cervantes Co. Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
